Ogivri and Nausea - a phase IV clinical study of FDA data
Summary:
Nausea is reported as a side effect among people who take Ogivri (trastuzumab-dkst), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Docetaxel, and have Breast cancer.
The phase IV clinical study analyzes which people have Nausea when taking Ogivri. It is created by eHealthMe based on reports of 196 people who have side effects when taking Ogivri from the FDA, and is updated regularly.
What is Ogivri?
Ogivri has active ingredients of trastuzumab-dkst. eHealthMe is studying from 197 Ogivri users. Check the latest studies of Ogivri.
What is Nausea?
Nausea (feeling of having an urge to vomit) is found to be associated with 3,889 drugs and 5,634 conditions by eHealthMe. Check the latest studies of Nausea.
196 people reported to have side effects when taking Ogivri.
Among them, 12 people (6.12%) have Nausea.

Among these 12 people:
How long have people been on Ogivri when they have Nausea? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Nausea when taking Ogivri? *
- female: 100 %
- male: 0.0 %
What is the age of people who have Nausea when taking Ogivri? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 37.5 %
- 60+: 50.0 %
What are other drugs people take besides Ogivri? *
- Zopiclone: 1 person, 8.33%
- Zoledronic Acid: 1 person, 8.33%
- Kadcyla: 1 person, 8.33%
- Ibrance: 1 person, 8.33%
- Ginger: 1 person, 8.33%
- Gemcitabine: 1 person, 8.33%
- Exemestane: 1 person, 8.33%
- Escitalopram Oxalate: 1 person, 8.33%
- Emend: 1 person, 8.33%
- Docetaxel: 1 person, 8.33%
What are other side effects people have besides Nausea? *
- Dizziness: 4 people, 33.33%
- Rhinorrhea (watery mucus discharge from the nose): 4 people, 33.33%
- Fatigue (feeling of tiredness): 4 people, 33.33%
- Nausea And Vomiting: 4 people, 33.33%
- Cough: 4 people, 33.33%
- Weight Decreased: 3 people, 25.00%
- Diarrhea: 3 people, 25.00%
- Pain: 3 people, 25.00%
- Rashes (redness): 3 people, 25.00%
- Headache (pain in head): 3 people, 25.00%
What are the existing conditions these people have? *
- Breast Cancer: 5 people, 41.67%
- Breast Cancer Metastatic: 3 people, 25.00%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 8.33%
- Neoplasm Malignant (cancer tumour): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Ogivri and have Nausea?
- Check whether Nausea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ogivri:
- Ogivri (197 reports)
Nausea treatments and more:
- Nausea (962,089 reports)
How severe was Nausea and when was it recovered:
Expand to all the drugs that have ingredients of trastuzumab-dkst:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ogivri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nausea:
- Nausea (3,889 drugs)
Browse all the conditions that are associated with Nausea:
- Nausea (5,634 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on trastuzumab-dkst (the active ingredients of Ogivri) and Ogivri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lotrisone and Maxalt - 4 seconds ago
- Anal Ulcer and drugs of ingredients of lactulose - 17 seconds ago
- Could Serevent cause Itching? - 17 seconds ago
- Could Yervoy cause Tooth Abscess? - 22 seconds ago
- Collapse and drugs of ingredients of simvastatin - 31 seconds ago
- Lortab vs. Sulfasalazine, side effect and effectiveness comparison - 39 seconds ago
- Could Leflunomide cause Hypovolaemic Shock? - 40 seconds ago
- Broken Bone and drugs of ingredients of rifaximin - 42 seconds ago
- Drug interactions of Zithromax and Depo-Medrol - 55 seconds ago
- Androgenetic Alopecia and Constipation - a minute ago